H.R. 5665 (119th)Bill Overview

ACE Veterans Act

Armed Forces and National Security|Armed Forces and National Security
Cosponsors
Support
Unknown
Introduced
Sep 30, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Veterans' Affairs.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill would add a new section to title 38, United States Code, directing the Secretary of Veterans Affairs to allow enrolled veterans to elect to fill prescriptions for contraceptive pills, transdermal patches, vaginal rings, and other contraceptive products as a full‑year supply. Department medical providers who prescribe those products must notify veterans that the full‑year supply option is available.

Why people may split

Scope and inclusions: liberals expect broad access (including emergency contraception and related services); conservatives seek clearer limits — the bill’s language is somewhat ambiguous.

Watch point

Relative to its intended legislative type, this bill is a clear, narrowly scoped substantive policy change that prescribes a new access option and a provider notice requirement and integrates by amending title 38.

The bill would add a new section to title 38, United States Code, directing the Secretary of Veterans Affairs to allow enrolled veterans to elect to fill prescriptions for contraceptive pills, transdermal patches, vaginal rings, and other contraceptive products as a full‑year supply.

Department medical providers who prescribe those products must notify veterans that the full‑year supply option is available.

The bill defines "contraceptive product" by cross‑reference to relevant Food and Drug Administration and Public Health Service statutory authorities.

Passage45/100

On content alone, the bill is a narrowly tailored, low-complexity administrative change within VA that many Members historically support as a veterans' benefit improvement. Its modest fiscal footprint and opt-in design increase prospects. However, the subject (contraception) carries some ideological sensitivity that could attract opposition from certain Members and complicate floor consideration in the Senate, keeping the likelihood from being high.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a clear, narrowly scoped substantive policy change that prescribes a new access option and a provider notice requirement and integrates by amending title 38. It does not, however, provide detailed implementation, fiscal, or accountability provisions.

Contention60/100

Scope and inclusions: liberals expect broad access (including emergency contraception and related services); conservatives seek clearer limits — the bill’s language is somewhat ambiguous.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
VeteransLikely burdened

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • VeteransImproved access and continuity of contraception for veterans by reducing gaps between refills, which supporters say can…
  • VeteransReduced patient time and travel costs because veterans would need fewer visits or pharmacy trips to maintain contracept…
  • Potential benefitPotential downstream health‑care cost savings for VA—if full‑year dispensing reduces unintended pregnancies and related…
Likely burdened
  • Potential burdenShort‑term increases in VA pharmacy expenditures and inventory carrying costs because pharmacies would dispense larger…
  • Potential burdenImplementation and administrative burden for VA, including updating prescribing/dispensing policies, electronic health…
  • Potential burdenPotential operational challenges or legal/ethical objections for individual VA providers, pharmacists, or contracted ph…
03 · Why people split

Why the argument around this bill splits.

Scope and inclusions: liberals expect broad access (including emergency contraception and related services); conservatives seek clearer limits — the bill’s language is somewhat ambiguous.
Progressive95%

A mainstream liberal would likely view this bill positively as a straightforward expansion of reproductive health access within VA care.

They would see it as removing a common logistical barrier to contraception continuity (fewer pharmacy visits, better adherence) and as advancing gender equity for veterans.

They would also note the statutory clarity provided by aligning the definition of contraceptive products with FDA/PHSA authorities.

Leans supportive
Centrist75%

A centrist would generally view this measure as a modest, pragmatic expansion of an existing medical convenience that could improve patient adherence and reduce administrative load.

They would weigh the public‑health and operational benefits against potential short‑term costs and logistics for VA pharmacies.

Overall, a centrist would likely favor the bill if it is fiscally responsible, administratively feasible, and preserves clinician judgment and patient choice.

Leans supportive
Conservative30%

A mainstream conservative reaction would vary: some conservatives may accept a limited veterans’ benefit expansion for practical reasons, while others would object to perceived expansion of federal involvement in contraception or to costs.

Concerns would focus on fiscal impact, federal overreach into medical practice, and potential conflicts with conscience or contractor rights.

Many conservatives might be more supportive if the policy is limited to enrolled veterans, does not mandate new appropriations, and preserves clinical discretion.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood45/100

On content alone, the bill is a narrowly tailored, low-complexity administrative change within VA that many Members historically support as a veterans' benefit improvement. Its modest fiscal footprint and opt-in design increase prospects. However, the subject (contraception) carries some ideological sensitivity that could attract opposition from certain Members and complicate floor consideration in the Senate, keeping the likelihood from being high.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • No Congressional Budget Office (CBO) cost estimate is included in the text; the fiscal impact (up-front pharmacy costs versus potential savings from improved adherence) is unknown and could affect support.
  • Practical implementation questions are not detailed: e.g., pharmacy supply-chain and inventory implications, whether cost-sharing or copay rules change for year supplies, and how dispensing limits or refills would be administratively handled.
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Scope and inclusions: liberals expect broad access (including emergency contraception and related services); conservatives seek clearer lim…

On content alone, the bill is a narrowly tailored, low-complexity administrative change within VA that many Members historically support as…

Unlocked analysis

Relative to its intended legislative type, this bill is a clear, narrowly scoped substantive policy change that prescribes a new access option and a provider notice requirement and integrates by amending title 38. It do…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis